Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO3409 | Goniothalamus leiocarpus | Species | Annonaceae | Eukaryota | TCM_Taiwan* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 5400 | nM | 20392543 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 2400 | nM | 20392543 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 9100 | nM | 20392543 |
NPT2 | Others | Unspecified | IC50 | = | 5400 | nM | 20392543 | |
NPT3470 | Cell Line | WEHI-164 | Mus musculus | IC50 | = | 8500 | nM | 20392543 |
NPT168 | Cell Line | P388 | Mus musculus | IC50 | = | 3800 | nM | 20392543 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 10100 | nM | 20392543 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 3500 | nM | 20392543 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 3000 | nM | 20392543 |
NPT2 | Others | Unspecified | Inhibition | = | 50 | % | 20729093 | |
NPT2 | Others | Unspecified | Inhibition | = | 41.7 | % | 20729093 | |
NPT2 | Others | Unspecified | Inhibition | = | 35.7 | % | 20729093 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | TGI | = | 23250 | nM | 20729093 |
NPT83 | Cell Line | MCF7 | Homo sapiens | TGI | = | 22680 | nM | 20729093 |
NPT2 | Others | Unspecified | TGI | = | 6380 | nM | 20729093 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | TGI | = | 22380 | nM | 20729093 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | TGI | = | 36350 | nM | 20729093 |
NPT2 | Others | Unspecified | TGI | = | 18240 | nM | 20729093 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | TGI | = | 18810 | nM | 20729093 |
NPT139 | Cell Line | HT-29 | Homo sapiens | TGI | = | 29210 | nM | 20729093 |
NPT380 | Cell Line | U-251 | Homo sapiens | TGI | = | 18160 | nM | 20729093 |
NPT2 | Others | Unspecified | Inhibition | = | 48.5 | % | 20729093 | |
NPT2 | Others | Unspecified | Inhibition | = | 40.9 | % | 20729093 | |
NPT2 | Others | Unspecified | Inhibition | = | 66.7 | % | 20729093 | |
NPT2 | Others | Unspecified | Inhibition | = | 41.8 | % | 20729093 | |
NPT2 | Others | Unspecified | Inhibition | = | 31.6 | % | 20729093 | |
NPT2 | Others | Unspecified | Inhibition | = | 36.7 | % | 20729093 | |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 3548.1 | nM | PubChem BioAssay data set |
NPT1197 | Individual Protein | Huntingtin | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 6309.6 | nM | PubChem BioAssay data set |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 2238.7 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | = | 1315 | nM | PubChem BioAssay data set | |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 25929 | nM | PubChem BioAssay data set | |
NPT2891 | Cell Line | H4 | Homo sapiens | EC50 | = | 98342 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 223.9 | nM | PubChem BioAssay data set |
NPT3246 | Individual Protein | Tyrosine-protein kinase JAK2 | Homo sapiens | IC50 | = | 8516 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | EC50 | > | 120000 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 2592.9 | nM | PubChem BioAssay data set | |
NPT3246 | Individual Protein | Tyrosine-protein kinase JAK2 | Homo sapiens | Activity | = | 2.046 | um | PubChem BioAssay data set |
NPT3246 | Individual Protein | Tyrosine-protein kinase JAK2 | Homo sapiens | Activity | = | 7.406 | um | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 5173.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | = | 22200 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 170 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | > | 80000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 2180 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 18356.4 | nM | PubChem BioAssay data set | |
NPT15 | Cell Line | Jurkat | Homo sapiens | Inhibition | = | 90.13 | % | 21873054 |
NPT15 | Cell Line | Jurkat | Homo sapiens | Inhibition | = | 12.72 | % | 21873054 |
NPT15 | Cell Line | Jurkat | Homo sapiens | Inhibition | = | 145.15 | % | 21873054 |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1000 | nM | PubChem BioAssay data set | ||
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 5804.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 8199.5 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 14581 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 16360.1 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 2511.9 | nM | PubChem BioAssay data set | |
NPT821 | Individual Protein | Werner syndrome ATP-dependent helicase | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT159 | Individual Protein | Aberrant vpr protein | Human immunodeficiency virus 1 | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 3662.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4109.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2310.9 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 20596.2 | nM | PubChem BioAssay data set | |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 18356.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 891.3 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 5623.4 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 1299.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC324835 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC308619 |
1.0 | High Similarity | NPC127491 |
0.9487 | High Similarity | NPC89950 |
0.9351 | High Similarity | NPC176228 |
0.9268 | High Similarity | NPC169050 |
0.9268 | High Similarity | NPC286608 |
0.9241 | High Similarity | NPC71795 |
0.9231 | High Similarity | NPC78517 |
0.9231 | High Similarity | NPC167577 |
0.9125 | High Similarity | NPC99240 |
0.9059 | High Similarity | NPC472319 |
0.9012 | High Similarity | NPC208183 |
0.9012 | High Similarity | NPC243289 |
0.9 | High Similarity | NPC303245 |
0.8974 | High Similarity | NPC287790 |
0.8974 | High Similarity | NPC3672 |
0.8953 | High Similarity | NPC77273 |
0.8846 | High Similarity | NPC175393 |
0.8795 | High Similarity | NPC53299 |
0.8636 | High Similarity | NPC23453 |
0.8588 | High Similarity | NPC96625 |
0.8506 | High Similarity | NPC240108 |
0.8506 | High Similarity | NPC213156 |
0.8409 | Intermediate Similarity | NPC119631 |
0.8391 | Intermediate Similarity | NPC173443 |
0.837 | Intermediate Similarity | NPC98911 |
0.837 | Intermediate Similarity | NPC472318 |
0.8276 | Intermediate Similarity | NPC304760 |
0.825 | Intermediate Similarity | NPC32203 |
0.825 | Intermediate Similarity | NPC206800 |
0.814 | Intermediate Similarity | NPC58616 |
0.8105 | Intermediate Similarity | NPC234305 |
0.8021 | Intermediate Similarity | NPC171831 |
0.8021 | Intermediate Similarity | NPC85977 |
0.8021 | Intermediate Similarity | NPC280616 |
0.8021 | Intermediate Similarity | NPC242913 |
0.7955 | Intermediate Similarity | NPC89377 |
0.7952 | Intermediate Similarity | NPC50192 |
0.7889 | Intermediate Similarity | NPC185501 |
0.7872 | Intermediate Similarity | NPC135951 |
0.7872 | Intermediate Similarity | NPC154517 |
0.7857 | Intermediate Similarity | NPC472316 |
0.7857 | Intermediate Similarity | NPC472315 |
0.7857 | Intermediate Similarity | NPC475203 |
0.7857 | Intermediate Similarity | NPC474376 |
0.7857 | Intermediate Similarity | NPC136962 |
0.7857 | Intermediate Similarity | NPC37115 |
0.7857 | Intermediate Similarity | NPC170484 |
0.7848 | Intermediate Similarity | NPC16190 |
0.7848 | Intermediate Similarity | NPC235059 |
0.7848 | Intermediate Similarity | NPC169222 |
0.7789 | Intermediate Similarity | NPC80115 |
0.7789 | Intermediate Similarity | NPC118343 |
0.7778 | Intermediate Similarity | NPC220893 |
0.7778 | Intermediate Similarity | NPC20485 |
0.7778 | Intermediate Similarity | NPC475465 |
0.7778 | Intermediate Similarity | NPC472314 |
0.7778 | Intermediate Similarity | NPC277788 |
0.7778 | Intermediate Similarity | NPC47536 |
0.7766 | Intermediate Similarity | NPC270654 |
0.7766 | Intermediate Similarity | NPC276775 |
0.7766 | Intermediate Similarity | NPC92754 |
0.7766 | Intermediate Similarity | NPC249912 |
0.7765 | Intermediate Similarity | NPC121800 |
0.7732 | Intermediate Similarity | NPC82426 |
0.7732 | Intermediate Similarity | NPC91820 |
0.7727 | Intermediate Similarity | NPC475710 |
0.7722 | Intermediate Similarity | NPC311343 |
0.7708 | Intermediate Similarity | NPC42211 |
0.77 | Intermediate Similarity | NPC40178 |
0.7684 | Intermediate Similarity | NPC78701 |
0.7684 | Intermediate Similarity | NPC35448 |
0.7684 | Intermediate Similarity | NPC225060 |
0.7677 | Intermediate Similarity | NPC51174 |
0.7677 | Intermediate Similarity | NPC477251 |
0.766 | Intermediate Similarity | NPC30361 |
0.7654 | Intermediate Similarity | NPC155429 |
0.7654 | Intermediate Similarity | NPC326200 |
0.7625 | Intermediate Similarity | NPC98880 |
0.7614 | Intermediate Similarity | NPC44546 |
0.7604 | Intermediate Similarity | NPC146351 |
0.7586 | Intermediate Similarity | NPC103387 |
0.7586 | Intermediate Similarity | NPC323103 |
0.7579 | Intermediate Similarity | NPC325499 |
0.7553 | Intermediate Similarity | NPC5472 |
0.7553 | Intermediate Similarity | NPC130398 |
0.7551 | Intermediate Similarity | NPC301943 |
0.7551 | Intermediate Similarity | NPC179686 |
0.7551 | Intermediate Similarity | NPC304638 |
0.7551 | Intermediate Similarity | NPC474365 |
0.7549 | Intermediate Similarity | NPC474157 |
0.7531 | Intermediate Similarity | NPC95289 |
0.7526 | Intermediate Similarity | NPC70624 |
0.75 | Intermediate Similarity | NPC270507 |
0.7476 | Intermediate Similarity | NPC234376 |
0.7475 | Intermediate Similarity | NPC109637 |
0.7475 | Intermediate Similarity | NPC114594 |
0.7471 | Intermediate Similarity | NPC165212 |
0.7426 | Intermediate Similarity | NPC260952 |
0.7423 | Intermediate Similarity | NPC325497 |
0.7412 | Intermediate Similarity | NPC179726 |
0.7404 | Intermediate Similarity | NPC272524 |
0.7404 | Intermediate Similarity | NPC265002 |
0.74 | Intermediate Similarity | NPC269457 |
0.74 | Intermediate Similarity | NPC127676 |
0.74 | Intermediate Similarity | NPC128730 |
0.74 | Intermediate Similarity | NPC209632 |
0.74 | Intermediate Similarity | NPC472919 |
0.7374 | Intermediate Similarity | NPC60679 |
0.7353 | Intermediate Similarity | NPC114741 |
0.7353 | Intermediate Similarity | NPC469636 |
0.7353 | Intermediate Similarity | NPC206341 |
0.7353 | Intermediate Similarity | NPC184633 |
0.7353 | Intermediate Similarity | NPC182549 |
0.7353 | Intermediate Similarity | NPC265407 |
0.7353 | Intermediate Similarity | NPC474364 |
0.7353 | Intermediate Similarity | NPC83628 |
0.7347 | Intermediate Similarity | NPC253746 |
0.7333 | Intermediate Similarity | NPC308744 |
0.7333 | Intermediate Similarity | NPC294134 |
0.7327 | Intermediate Similarity | NPC176971 |
0.7327 | Intermediate Similarity | NPC326447 |
0.7308 | Intermediate Similarity | NPC158282 |
0.7284 | Intermediate Similarity | NPC78954 |
0.7284 | Intermediate Similarity | NPC82770 |
0.7284 | Intermediate Similarity | NPC239931 |
0.7282 | Intermediate Similarity | NPC149545 |
0.7273 | Intermediate Similarity | NPC188895 |
0.7273 | Intermediate Similarity | NPC94343 |
0.7264 | Intermediate Similarity | NPC474685 |
0.7255 | Intermediate Similarity | NPC151530 |
0.7255 | Intermediate Similarity | NPC157473 |
0.7245 | Intermediate Similarity | NPC203925 |
0.7245 | Intermediate Similarity | NPC171843 |
0.7241 | Intermediate Similarity | NPC469894 |
0.7238 | Intermediate Similarity | NPC474176 |
0.7238 | Intermediate Similarity | NPC128368 |
0.7228 | Intermediate Similarity | NPC139891 |
0.7212 | Intermediate Similarity | NPC476003 |
0.7212 | Intermediate Similarity | NPC323007 |
0.7212 | Intermediate Similarity | NPC43584 |
0.7212 | Intermediate Similarity | NPC210089 |
0.7212 | Intermediate Similarity | NPC183700 |
0.7209 | Intermediate Similarity | NPC329318 |
0.7204 | Intermediate Similarity | NPC9822 |
0.72 | Intermediate Similarity | NPC89886 |
0.7196 | Intermediate Similarity | NPC473507 |
0.7196 | Intermediate Similarity | NPC149691 |
0.7191 | Intermediate Similarity | NPC106313 |
0.7184 | Intermediate Similarity | NPC99846 |
0.7184 | Intermediate Similarity | NPC269023 |
0.7174 | Intermediate Similarity | NPC194326 |
0.7157 | Intermediate Similarity | NPC119271 |
0.7143 | Intermediate Similarity | NPC179411 |
0.7143 | Intermediate Similarity | NPC470825 |
0.7143 | Intermediate Similarity | NPC139946 |
0.7143 | Intermediate Similarity | NPC474314 |
0.7143 | Intermediate Similarity | NPC185840 |
0.7129 | Intermediate Similarity | NPC269644 |
0.7129 | Intermediate Similarity | NPC2518 |
0.7128 | Intermediate Similarity | NPC108026 |
0.7128 | Intermediate Similarity | NPC26224 |
0.7126 | Intermediate Similarity | NPC76455 |
0.7126 | Intermediate Similarity | NPC137847 |
0.7115 | Intermediate Similarity | NPC273837 |
0.7111 | Intermediate Similarity | NPC288903 |
0.7103 | Intermediate Similarity | NPC210092 |
0.7087 | Intermediate Similarity | NPC56493 |
0.7083 | Intermediate Similarity | NPC261181 |
0.7079 | Intermediate Similarity | NPC73978 |
0.7075 | Intermediate Similarity | NPC161611 |
0.7065 | Intermediate Similarity | NPC318107 |
0.7059 | Intermediate Similarity | NPC288760 |
0.7059 | Intermediate Similarity | NPC227255 |
0.7053 | Intermediate Similarity | NPC475023 |
0.7053 | Intermediate Similarity | NPC475059 |
0.7048 | Intermediate Similarity | NPC167504 |
0.7045 | Intermediate Similarity | NPC300205 |
0.7045 | Intermediate Similarity | NPC139901 |
0.7045 | Intermediate Similarity | NPC151405 |
0.7041 | Intermediate Similarity | NPC289201 |
0.7037 | Intermediate Similarity | NPC476476 |
0.7037 | Intermediate Similarity | NPC100353 |
0.7019 | Intermediate Similarity | NPC10251 |
0.7019 | Intermediate Similarity | NPC281604 |
0.7019 | Intermediate Similarity | NPC17417 |
0.7011 | Intermediate Similarity | NPC245966 |
0.701 | Intermediate Similarity | NPC32977 |
0.701 | Intermediate Similarity | NPC473347 |
0.701 | Intermediate Similarity | NPC81010 |
0.7009 | Intermediate Similarity | NPC87069 |
0.7009 | Intermediate Similarity | NPC474363 |
0.7009 | Intermediate Similarity | NPC307651 |
0.7009 | Intermediate Similarity | NPC474641 |
0.7 | Intermediate Similarity | NPC13755 |
0.699 | Remote Similarity | NPC37622 |
0.699 | Remote Similarity | NPC30594 |
0.6981 | Remote Similarity | NPC79496 |
0.6981 | Remote Similarity | NPC477250 |
0.6979 | Remote Similarity | NPC475057 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC324835 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9268 | High Similarity | NPD1282 | Approved |
0.825 | Intermediate Similarity | NPD9716 | Approved |
0.8182 | Intermediate Similarity | NPD689 | Discontinued |
0.7789 | Intermediate Similarity | NPD1238 | Approved |
0.75 | Intermediate Similarity | NPD3971 | Phase 1 |
0.75 | Intermediate Similarity | NPD5926 | Approved |
0.7327 | Intermediate Similarity | NPD3134 | Approved |
0.7255 | Intermediate Similarity | NPD1358 | Approved |
0.7228 | Intermediate Similarity | NPD9697 | Approved |
0.7212 | Intermediate Similarity | NPD2181 | Clinical (unspecified phase) |
0.72 | Intermediate Similarity | NPD6647 | Phase 2 |
0.7143 | Intermediate Similarity | NPD5734 | Clinical (unspecified phase) |
0.7129 | Intermediate Similarity | NPD5909 | Discontinued |
0.7115 | Intermediate Similarity | NPD2067 | Discontinued |
0.7083 | Intermediate Similarity | NPD1202 | Approved |
0.7065 | Intermediate Similarity | NPD9257 | Approved |
0.7065 | Intermediate Similarity | NPD9259 | Approved |
0.7019 | Intermediate Similarity | NPD2182 | Approved |
0.6981 | Remote Similarity | NPD969 | Suspended |
0.6961 | Remote Similarity | NPD164 | Approved |
0.6932 | Remote Similarity | NPD227 | Approved |
0.6932 | Remote Similarity | NPD225 | Approved |
0.6889 | Remote Similarity | NPD942 | Approved |
0.6854 | Remote Similarity | NPD9490 | Approved |
0.68 | Remote Similarity | NPD9495 | Approved |
0.6778 | Remote Similarity | NPD1507 | Clinical (unspecified phase) |
0.6771 | Remote Similarity | NPD3672 | Approved |
0.6771 | Remote Similarity | NPD3673 | Approved |
0.6771 | Remote Similarity | NPD9258 | Approved |
0.6771 | Remote Similarity | NPD9256 | Approved |
0.6768 | Remote Similarity | NPD1989 | Approved |
0.6739 | Remote Similarity | NPD9491 | Approved |
0.6733 | Remote Similarity | NPD7798 | Approved |
0.6703 | Remote Similarity | NPD226 | Approved |
0.6667 | Remote Similarity | NPD6049 | Phase 2 |
0.6667 | Remote Similarity | NPD694 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD6048 | Clinical (unspecified phase) |
0.6635 | Remote Similarity | NPD1237 | Approved |
0.6632 | Remote Similarity | NPD650 | Approved |
0.6629 | Remote Similarity | NPD9294 | Approved |
0.6571 | Remote Similarity | NPD5048 | Discontinued |
0.6569 | Remote Similarity | NPD2066 | Phase 3 |
0.6566 | Remote Similarity | NPD5122 | Clinical (unspecified phase) |
0.6549 | Remote Similarity | NPD9545 | Approved |
0.6545 | Remote Similarity | NPD1241 | Discontinued |
0.6545 | Remote Similarity | NPD6010 | Discontinued |
0.6538 | Remote Similarity | NPD5738 | Clinical (unspecified phase) |
0.6514 | Remote Similarity | NPD1609 | Clinical (unspecified phase) |
0.6509 | Remote Similarity | NPD5705 | Approved |
0.6509 | Remote Similarity | NPD5704 | Approved |
0.6509 | Remote Similarity | NPD5706 | Approved |
0.6505 | Remote Similarity | NPD2555 | Approved |
0.6505 | Remote Similarity | NPD2550 | Approved |
0.6505 | Remote Similarity | NPD2549 | Approved |
0.6505 | Remote Similarity | NPD2558 | Approved |
0.6505 | Remote Similarity | NPD2553 | Approved |
0.6505 | Remote Similarity | NPD2552 | Approved |
0.65 | Remote Similarity | NPD9260 | Approved |
0.6486 | Remote Similarity | NPD690 | Clinical (unspecified phase) |
0.6481 | Remote Similarity | NPD5235 | Approved |
0.6481 | Remote Similarity | NPD5240 | Approved |
0.6481 | Remote Similarity | NPD5237 | Approved |
0.6481 | Remote Similarity | NPD5236 | Approved |
0.6481 | Remote Similarity | NPD5239 | Approved |
0.646 | Remote Similarity | NPD2347 | Approved |
0.6458 | Remote Similarity | NPD1087 | Approved |
0.6442 | Remote Similarity | NPD4188 | Approved |
0.6442 | Remote Similarity | NPD4189 | Approved |
0.6441 | Remote Similarity | NPD2198 | Approved |
0.6441 | Remote Similarity | NPD2199 | Approved |
0.6429 | Remote Similarity | NPD4198 | Discontinued |
0.6422 | Remote Similarity | NPD2201 | Approved |
0.641 | Remote Similarity | NPD6637 | Approved |
0.6386 | Remote Similarity | NPD675 | Discontinued |
0.6381 | Remote Similarity | NPD1929 | Approved |
0.6381 | Remote Similarity | NPD1930 | Approved |
0.6381 | Remote Similarity | NPD1931 | Clinical (unspecified phase) |
0.6372 | Remote Similarity | NPD9493 | Approved |
0.6364 | Remote Similarity | NPD7609 | Phase 3 |
0.6364 | Remote Similarity | NPD1239 | Approved |
0.6348 | Remote Similarity | NPD5691 | Approved |
0.6344 | Remote Similarity | NPD9250 | Approved |
0.6339 | Remote Similarity | NPD2629 | Approved |
0.6327 | Remote Similarity | NPD800 | Approved |
0.6325 | Remote Similarity | NPD6287 | Discontinued |
0.6321 | Remote Similarity | NPD3046 | Approved |
0.6321 | Remote Similarity | NPD3047 | Approved |
0.6321 | Remote Similarity | NPD3048 | Approved |
0.6311 | Remote Similarity | NPD5454 | Clinical (unspecified phase) |
0.6306 | Remote Similarity | NPD5535 | Approved |
0.6306 | Remote Similarity | NPD6858 | Approved |
0.6306 | Remote Similarity | NPD7094 | Approved |
0.63 | Remote Similarity | NPD1508 | Approved |
0.63 | Remote Similarity | NPD7631 | Approved |
0.6289 | Remote Similarity | NPD4793 | Discontinued |
0.6289 | Remote Similarity | NPD506 | Clinical (unspecified phase) |
0.6286 | Remote Similarity | NPD1932 | Approved |
0.6263 | Remote Similarity | NPD1086 | Approved |
0.6263 | Remote Similarity | NPD1089 | Approved |
0.6263 | Remote Similarity | NPD1090 | Approved |
0.6261 | Remote Similarity | NPD1894 | Discontinued |
0.6239 | Remote Similarity | NPD6831 | Clinical (unspecified phase) |
0.6239 | Remote Similarity | NPD3496 | Discontinued |
0.6238 | Remote Similarity | NPD1563 | Approved |
0.6238 | Remote Similarity | NPD1066 | Discontinued |
0.6226 | Remote Similarity | NPD9261 | Approved |
0.6224 | Remote Similarity | NPD531 | Approved |
0.6207 | Remote Similarity | NPD5585 | Approved |
0.6207 | Remote Similarity | NPD9497 | Clinical (unspecified phase) |
0.6204 | Remote Similarity | NPD2551 | Approved |
0.6204 | Remote Similarity | NPD2559 | Approved |
0.6204 | Remote Similarity | NPD811 | Approved |
0.6204 | Remote Similarity | NPD3526 | Approved |
0.6204 | Remote Similarity | NPD3524 | Approved |
0.6204 | Remote Similarity | NPD812 | Approved |
0.6204 | Remote Similarity | NPD6685 | Approved |
0.6204 | Remote Similarity | NPD810 | Approved |
0.6204 | Remote Similarity | NPD968 | Approved |
0.62 | Remote Similarity | NPD1007 | Discontinued |
0.6186 | Remote Similarity | NPD422 | Phase 1 |
0.6186 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.6176 | Remote Similarity | NPD688 | Clinical (unspecified phase) |
0.6176 | Remote Similarity | NPD1693 | Approved |
0.6162 | Remote Similarity | NPD5347 | Phase 2 |
0.6162 | Remote Similarity | NPD5346 | Phase 2 |
0.6147 | Remote Similarity | NPD290 | Approved |
0.6139 | Remote Similarity | NPD1088 | Approved |
0.6118 | Remote Similarity | NPD173 | Clinical (unspecified phase) |
0.6117 | Remote Similarity | NPD1843 | Approved |
0.6098 | Remote Similarity | NPD6832 | Phase 2 |
0.6095 | Remote Similarity | NPD9712 | Approved |
0.6087 | Remote Similarity | NPD5291 | Approved |
0.6087 | Remote Similarity | NPD5292 | Approved |
0.6087 | Remote Similarity | NPD4431 | Clinical (unspecified phase) |
0.6075 | Remote Similarity | NPD5765 | Approved |
0.6066 | Remote Similarity | NPD6007 | Clinical (unspecified phase) |
0.6066 | Remote Similarity | NPD1019 | Discontinued |
0.6058 | Remote Similarity | NPD1566 | Phase 3 |
0.6058 | Remote Similarity | NPD1564 | Approved |
0.6058 | Remote Similarity | NPD3495 | Discontinued |
0.6058 | Remote Similarity | NPD1565 | Approved |
0.6048 | Remote Similarity | NPD5952 | Clinical (unspecified phase) |
0.6048 | Remote Similarity | NPD7008 | Discontinued |
0.6036 | Remote Similarity | NPD1752 | Approved |
0.6036 | Remote Similarity | NPD1756 | Approved |
0.6036 | Remote Similarity | NPD551 | Approved |
0.6036 | Remote Similarity | NPD550 | Approved |
0.6036 | Remote Similarity | NPD3646 | Clinical (unspecified phase) |
0.6034 | Remote Similarity | NPD5536 | Phase 2 |
0.6033 | Remote Similarity | NPD3225 | Approved |
0.6033 | Remote Similarity | NPD5667 | Approved |
0.6017 | Remote Similarity | NPD1778 | Approved |
0.6017 | Remote Similarity | NPD4626 | Approved |
0.6 | Remote Similarity | NPD9717 | Approved |
0.6 | Remote Similarity | NPD9267 | Approved |
0.6 | Remote Similarity | NPD9265 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD5979 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD9263 | Approved |
0.6 | Remote Similarity | NPD9711 | Approved |
0.6 | Remote Similarity | NPD9710 | Approved |
0.6 | Remote Similarity | NPD9264 | Approved |
0.5984 | Remote Similarity | NPD2797 | Approved |
0.5984 | Remote Similarity | NPD3266 | Approved |
0.5984 | Remote Similarity | NPD9567 | Approved |
0.5984 | Remote Similarity | NPD553 | Approved |
0.5984 | Remote Similarity | NPD552 | Approved |
0.5984 | Remote Similarity | NPD1203 | Approved |
0.5984 | Remote Similarity | NPD3267 | Approved |
0.5966 | Remote Similarity | NPD7457 | Clinical (unspecified phase) |
0.5963 | Remote Similarity | NPD794 | Clinical (unspecified phase) |
0.5962 | Remote Similarity | NPD5206 | Clinical (unspecified phase) |
0.595 | Remote Similarity | NPD4359 | Approved |
0.5948 | Remote Similarity | NPD4576 | Approved |
0.5948 | Remote Similarity | NPD4574 | Approved |
0.5946 | Remote Similarity | NPD74 | Approved |
0.5946 | Remote Similarity | NPD2329 | Discontinued |
0.5946 | Remote Similarity | NPD9266 | Approved |
0.5946 | Remote Similarity | NPD2684 | Approved |
0.5932 | Remote Similarity | NPD3535 | Clinical (unspecified phase) |
0.5929 | Remote Similarity | NPD4572 | Approved |
0.5929 | Remote Similarity | NPD4571 | Approved |
0.5929 | Remote Similarity | NPD9508 | Approved |
0.5929 | Remote Similarity | NPD6912 | Phase 3 |
0.5929 | Remote Similarity | NPD4573 | Approved |
0.5918 | Remote Similarity | NPD111 | Approved |
0.5917 | Remote Similarity | NPD518 | Clinical (unspecified phase) |
0.5917 | Remote Similarity | NPD4480 | Approved |
0.5913 | Remote Similarity | NPD5951 | Approved |
0.5909 | Remote Similarity | NPD467 | Phase 1 |
0.5906 | Remote Similarity | NPD7966 | Clinical (unspecified phase) |
0.5893 | Remote Similarity | NPD4233 | Approved |
0.5893 | Remote Similarity | NPD9713 | Approved |
0.5893 | Remote Similarity | NPD4234 | Approved |
0.5891 | Remote Similarity | NPD2569 | Approved |
0.5891 | Remote Similarity | NPD2567 | Approved |
0.5882 | Remote Similarity | NPD17 | Approved |
0.5882 | Remote Similarity | NPD5305 | Approved |
0.5882 | Remote Similarity | NPD3412 | Clinical (unspecified phase) |
0.5882 | Remote Similarity | NPD5306 | Approved |
0.5877 | Remote Similarity | NPD5277 | Phase 2 |
PubChem CID   | 5317826 |
ChEMBL   | CHEMBL1170485 |
ZINC   |
Molecular Weight:   | 200.08 |
ALogP:   | 0.943 |
MLogP:   | 2.67 |
XLogP:   | 4.876 |
# Rotatable Bonds:   | 2 |
Polar Surface Area:   | 26.3 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 0 |
# Rings:   | 2 |
# Heavy Atoms:   | 15 |